Physician
Rheumatic Disease Center
Rheumatic Disease Center was paid $2.99M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 35% of everything it billed.
33Billing provider infoRHEUMATIC DISEASE CENTER
GLENDALE, WI 53217
GLENDALE, WI 53217
33aNPI1609812544assigned 06/21/2006
33bProvider typeRheumatology Physician
28Total paid$2.99M
24GClaims95,022
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rheumatology Physician providers in Wisconsin
Rank by total paid#1 of 9
Median peer was paid$13K
This provider vs. median222×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,879 | $265K | |
| 2019 | 10,325 | $313K | |
| 2020 | 11,255 | $321K | |
| 2021 | 15,044 | $779K | |
| 2022 | 15,610 | $508K | |
| 2023 | 21,032 | $459K | |
| 2024incomplete | 10,877 | $341K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 35% | 759 | 485 | $1.05M |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 34% | 766 | 423 | $1.01M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.7% | 4,768 | 2,864 | $260K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7.3% | 262 | 160 | $217K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.8% | 7,081 | 6,045 | $174K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 2,789 | 2,387 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 10,379 | 7,835 | $38K |
| 86140 | <1% | 10,815 | 8,144 | $26K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 457 | 389 | $21K |
| 85651 | <1% | 10,865 | 8,188 | $19K | |
| 96415 | <1% | 1,300 | 727 | $17K | |
| 84460 | <1% | 7,003 | 5,142 | $15K |
35 more codes
| 82565 | <1% | 6,929 | $15K | |
| 82040 | <1% | 6,918 | $14K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,373 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 468 | $9K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 136 | $8K |
| 84450 | <1% | 1,841 | $5K | |
| 84550 | <1% | 1,194 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 995 | $2K |
| 96401 | <1% | 62 | $2K | |
| 86225 | <1% | 251 | $2K | |
| 99000 | <1% | 811 | $1K | |
| 86038 | <1% | 169 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,318 | $1K |
| 86200 | <1% | 122 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 93 | $1K |
| 86160 | <1% | 220 | $932.96 | |
| 86431 | <1% | 182 | $711.51 | |
| 82570 | <1% | 303 | $565.30 | |
| 84156 | <1% | 303 | $396.14 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,026 | $392.55 |
| 83970 | <1% | 16 | $319.93 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 80 | $316.76 |
| 82550 | <1% | 18 | $58.42 | |
| 82310 | <1% | 41 | $45.77 | |
| 81003 | <1% | 66 | $43.00 | |
| 1036F | 0% | 1,148 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 209 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 848 | $0.00 |
| 1006F | 0% | 14 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 16 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 580 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,638 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 1,195 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 139 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 56 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUSHI, JONATHAN (PHYSICIAN)